Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Honglu Li

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
European Journal of Radiology|April 2, 2020
Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT?Chunqin Long, Huaxiang Xu, Qinglin Shen, et al.
The British Journal of Radiology|November 27, 2020
Hepatocellular carcinoma with type II-III portal vein tumour thrombosis: treatment using transarterial chemoembolisation and microwave ablationWen Peng Zhao, Honglu Li, Jiang Guo, et al.
Clinics and Research in Hepatology and Gastroenterology|October 30, 2020
Drug-eluting bead transarterial chemoembolization is an effective downstaging option for subsequent radical treatments in patients with hepatocellular carcinoma: A cohort studyLiang Cai, Honglu Li, Jiang Guo, et al.
Clinics and Research in Hepatology and Gastroenterology|February 21, 2023
D-dimer for assessment of treatment response, and survival to drug-eluting beads transarterial chemoembolization in hepatocellular carcinomaYoujia Duan, Xiaopu Hou, Jiang Guo, et al.
Journal of Cancer Research and Therapeutics|December 1, 2021
Effect of microwave ablation on platelet and coagulation function in patients with BCLC-A hepatocellular carcinomaWenpeng Zhao, Honglu Li, Wei Li, et al.
American Journal of Translational Research|August 11, 2021
Drug-eluting beads-transarterial chemoembolization plus microwave ablation is an effective and safe treatment strategy in treating hepatocellular carcinoma adjacent to gallbladderLiang Cai, Honglu Li, Jiang Guo, et al.
Cancer Biology & Therapy|March 1, 2022
Treatment efficacy and safety of drug-eluting beads transarterial chemoembolization versus conventional transarterial chemoembolization in hepatocellular carcinoma patients with arterioportal fistulaLiang Cai, Honglu Li, Jiang Guo, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
European Journal of Radiology|April 2, 2020
Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT?Chunqin Long, Huaxiang Xu, Qinglin Shen, et al.
The British Journal of Radiology|November 27, 2020
Hepatocellular carcinoma with type II-III portal vein tumour thrombosis: treatment using transarterial chemoembolisation and microwave ablationWen Peng Zhao, Honglu Li, Jiang Guo, et al.
Clinics and Research in Hepatology and Gastroenterology|October 30, 2020
Drug-eluting bead transarterial chemoembolization is an effective downstaging option for subsequent radical treatments in patients with hepatocellular carcinoma: A cohort studyLiang Cai, Honglu Li, Jiang Guo, et al.
Clinics and Research in Hepatology and Gastroenterology|February 21, 2023
D-dimer for assessment of treatment response, and survival to drug-eluting beads transarterial chemoembolization in hepatocellular carcinomaYoujia Duan, Xiaopu Hou, Jiang Guo, et al.
Journal of Cancer Research and Therapeutics|December 1, 2021
Effect of microwave ablation on platelet and coagulation function in patients with BCLC-A hepatocellular carcinomaWenpeng Zhao, Honglu Li, Wei Li, et al.
American Journal of Translational Research|August 11, 2021
Drug-eluting beads-transarterial chemoembolization plus microwave ablation is an effective and safe treatment strategy in treating hepatocellular carcinoma adjacent to gallbladderLiang Cai, Honglu Li, Jiang Guo, et al.
Cancer Biology & Therapy|March 1, 2022
Treatment efficacy and safety of drug-eluting beads transarterial chemoembolization versus conventional transarterial chemoembolization in hepatocellular carcinoma patients with arterioportal fistulaLiang Cai, Honglu Li, Jiang Guo, et al.
Pageof 2